Search results
Weight loss drug shortage: Zepbound and Wegovy in short supply, says FDA
BenefitsPRO· 1 day agoThe U.S. Food and Drug Administration updated its drug shortage database in April to reflect that...
FDA Says It Will Take on Wider Regulation of Medical Tests. Is It Ready?
Bloomberg· 6 hours agoHi, it’s John in Boston. This week, the FDA signaled it may finally make a move that’s been on the...
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 minutes agoTandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call Transcript May 2, 2024 Tandem...
FDA finalizes lab developed test rule despite industry opposition
MedTech Dive via Yahoo Finance· 4 days agoThe rule amends agency regulations to make explicit that in vitro diagnostics are devices under the...
FDA clears Curio's postpartum depression PDT
NJBIZ· 1 hour agoCurio Digital Therapeutics Inc.’s MamaLife Plus offers a nonpharmaceutical alternative to treating postpartum depression. Princeton-based Curio announced...
FDA Finalizes LDT Regulation, with Significant Exceptions: Enforcement of Requirements Will Phase In...
JD Supra· 21 hours agoOn April 29, 2024, the Office of the Federal Register placed on display the Food and Drug Administration’s (FDA) final rule on the regulation of laboratory developed tests ...
Trade union’s legal challenge over Rwanda Act to be heard in June
Press Association News via AOL· 1 hour agoThe FDA trade union’s High Court challenge over the Government’s Safety of Rwanda Act will be heard...
FDA misses own deadline to propose ban on cancer-linked formaldehyde from hair relaxers
The Today Show via AOL· 21 hours agoThe FDA announced it would propose a ban on formaldehyde commonly found in hair relaxers typically...
FDA brings lab tests under federal oversight in bid to improve accuracy and safety
Boston Herald· 4 days agoThe goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and...
FDA approves Alecensa as leading-edge adjuvant therapy for ALK-positive lung cancer
Clinical Trials Arena via Yahoo Finance· 1 day agoOn 18 April 2024, the US Food and Drug Administration (FDA) approved Roche’s Alecensa (alectinib),...